Nanotechnology-based surface plasmon resonance affinity biosensors for in vitro diagnostics by Antiochia, Riccarda et al.
Review Article
Nanotechnology-Based Surface Plasmon Resonance Affinity
Biosensors for In Vitro Diagnostics
Riccarda Antiochia, Paolo Bollella, Gabriele Favero, and Franco Mazzei
Department of Chemistry and Drug Technologies, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy
Correspondence should be addressed to Franco Mazzei; franco.mazzei@uniroma1.it
Received 24 February 2016; Revised 5 July 2016; Accepted 10 July 2016
Academic Editor: Jiu-Ju Feng
Copyright © 2016 Riccarda Antiochia et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
In the last decades, in vitro diagnostic devices (IVDDs) became a very important tool in medicine for an early and correct
diagnosis, a proper screening of targeted population, and also assessing the efficiency of a specific therapy. In this review, the most
recent developments regarding different configurations of surface plasmon resonance affinity biosensors modified by using several
nanostructured materials for in vitro diagnostics are critically discussed. Both assembly and performances of the IVDDs tested in
biological samples are reported and compared.
1. Introduction
In the last two decades, the need to obtain early, affordable,
and reliable analytical devices for in vitro diagnostics has
become a key aspect on reaching the quick diagnosis of sev-
eral pathologies. This is important not only for the safeguard
of health and safety of patients but also for reducing the costs
of the National Health Systems. An ideal in vitro diagnostic
device (IVDD) should allow the qualitative and quantitative
detection of several pathologies of potential markers in
biological fluids and tissues, rather than in a living body [1].
The role played by the IVDDs is (i) to assure a fast screening
of populations (action: prevention of diseases); (ii) early and
accurate information (action: correct diagnosis); (iii) real-
time monitoring (action: evaluation of therapy treatments).
For these reasons the European Council fixed strict rules
for the characteristics and commercialization of IVDDs
(Directive 98/79/EC). In this context, a rigorous classification
based on an alphabetical system (Table 1) wasmade according
to the following criteria:
(i) Manufacturers should specify the use conditions and
the risk factor of IVDDs.
(ii) The obtained information should be relevant for a
careful diagnosis, taking into account the natural
history of diseases.
(iii) The results should affect, positively or negatively, the
public/individual health.
The official analytical methods generally employed for
biomedical applications are affected by several drawbacks:
being time-consuming, costs of analysis, laborious proce-
dures, the need for qualified personnel, and poor avail-
ability as point-of-care systems. In the last decades the
significant technological progress in several fields such as
nanotechnologies, electronics, and biotechnologies as well
as the need to have fast, sensitive, and user-friendly devices
resulted in the development of several analytical methods.
In this field, biosensors can play an important role for
some peculiar features. A biosensor is an analytical device
where a biotransducer (BT) (e.g., tissues, DNA, antibodies,
enzymes, etc.) is coupled to a physicochemical transducer
(e.g., electrochemical, optical, piezoelectric, or magnetic).
The interaction between the analyte and the biotransducer
results in a change of a physical or chemical property
detected by the physicochemical transducer and converted
into an electrical signal which, opportunely amplified and
elaborated, allows obtaining information about the sample
under investigation [2].
Among the different types of biosensors, the affinity-
based biosensors (ABBs) are considered the most suitable for
IVD analysis for some interesting properties: reduced costs
Hindawi Publishing Corporation
International Journal of Analytical Chemistry
Volume 2016, Article ID 2981931, 15 pages
http://dx.doi.org/10.1155/2016/2981931
2 International Journal of Analytical Chemistry
Table 1: General classification of IVDD.
Class Individual risk Public health risk Examples
A ∙ ∙ Selective/differential microbiological media, identificationkits for cultured microorganisms
B ∙∙ ∙ Hormones, vitamins, enzymes, metabolic markers
C ∙∙∙ ∙∙ PSA or CEA screening
D ∙∙∙ ∙∙∙ HIV, HCV, HBV, HTLV
(∙) Low, (∙∙) moderate, and (∙∙∙) high.
of analysis, selectivity, being easy to use, and furthermore
the reversible interaction between the biotransducer and the
analyte which allows the reuse of the biodevice for multiple
analyses. ABBs, characterized by the use of antibodies or
aptamers as biotransducers, provide interesting information
about the concentration of the analyte and also about the
kinetics and thermodynamics of the biotransducer-analyte
interaction.
Surface plasmon resonance- (SPR-) based transducers
show interesting features compared to other physicochemical
transducers, allowing real-timemonitoring of biotransducer-
analyte interactions, without the need of labeling. The bio-
transducer immobilized onto the sensor disk surface interacts
with the analyte producing a local increase in the refractive
index at themetal surface which promotes an SPR signal shift
[3, 4].
Besides several advantages of SPR transduction, some
drawbacks must be considered such as nonspecific binding
phenomena onto the SPR disk which can affect the accuracy
of the measurements in biological fluids, the difficulty of
immobilization of bioreceptors characterized by steric hin-
drance, and the inability to detect small molecules character-
ized by a low molecular weight. The key issue to overcome
these drawbacks is a proper sensor chip modification [5].
Recent technological advances in the field of nanotech-
nology allow the development of new nanostructured mate-
rials which have a great impact on the overall performances of
biosensors and in particular of SPR-based biosensors. Nanos-
tructuredmaterials can be useful to overcome the problem of
a low sensitivity due to small changes in the refractive index at
the SPR disk surface arising from analytes with lowmolecular
weight or low concentration values. The nanomodification
is important to increase the biotransducer loading thanks
to the high surface/volume ratio of these materials as well
as amplify the plasmonic signal [6–9]. Graphene and metal
nanoparticles (MNPs) show the most suitable characteristics
for sensor chipmodifications.Graphene coating improves the
change of the refractive index at the interface graphene/gold
sensor chip, thus modifying the SPR signal associated with
the thinmetal surface [10]. Metal nanoparticles, in particular,
gold and silver nanoparticles (AuNPs or AgNPs), displaying
a localized surface plasmon resonance (LSPR), are widely
used to enhance the SPR response [11, 12]. In fact, a change
in the SPR energy is observed thanks to the coupling of
LSP and the SP [13–17]. Some researchers studied the use of
AuNPs as amplifier labels for biorecognition events [18, 19],
biocatalytic transformations [20, 21], or sensitive detection of
low molecular weight compounds [22, 23].
The enhancement of the overall performances achieved
with the nanomodification of the SPR-based biosensors
results is of extreme importance for their application as
IVDDs [24, 25].
In this review, we describe and discuss the potential use
of nanomodified SPR-based biosensors for IVD applications.
In particular, three different SPR configurations have been
taken into account: (a) bulk SPR; (b) localized SPR; (c) SPR
imaging.
(a) Bulk SPR. This technique is based on the detection
of small changes in the refractive index on thin
metal films arising from the binding of analytes with
a specific biotransducer through the change in the
resonance angle. The use of nanoparticles increases
the bulk SPR sensitivity with a consequent reduction
of detection limit through two different mechanisms:
(i) the particular interaction between the electrical
field developed from metal nanoparticles and the
evanescent wave due to the plasmon surface excited
from light source [26]; (ii) the bioconjugation with a
biological recognition element, antibody or aptamer,
which enhances the molecular weight, as the SPR sig-
nal is directly proportional to the mass immobilized
on the surface. In the first case themetal nanoparticles
are incorporated onto or into the metallic surface
(Figure 1(a)), while in the second case they are utilized
in the so-called “sandwich assay” format (Figure 1(b))
where theMNPs, conjugatedwith secondary antibod-
ies or aptamers, are captured by the sensor surface
subsequent to the binding of the target analyte to the
primary biorecognition elements.
(b) Localized SPR. When the charge density oscillation
is confined to metallic nanoparticles or nanostruc-
tures the localized surface plasmon resonance (LSPR)
phenomenon is generated. When this occurs, there
is an incident light source that induces both light
scattering and a strong absorbance, with a consequent
enhancement of the local electromagnetic field [27]
(Figure 2). The frequency and the absorption bands
depend on the type of material (e.g., gold, silver, and
platinum) but also on the shape and size distribution
that realize particular conditions onto the surface
to enhance the SPR signal. Therefore the sensitivity
and selectivity can be modified by changing the
shape, size, and material composition of MNPs to
achieve ultrasensitivity and ultraselectivity thanks to
the novel nanoconfigurations [28]. Moreover, LSPR
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Figure 1: Scheme of bulk SPRwith (a) nanoparticles incorporated onto the surface and (b) sandwich “assay” with nanoparticles amplification.
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allows a simultaneous detection of different biomark-
ers with different concentrations, thus enabling high-
throughput screening in the array format [29].
(c) SPR Imaging. One of the last SPR approaches is the
surface plasmon resonance imaging (SPRi), a combi-
nation of SPR and a spatially resolved measurement
(Figure 3). This kind of resolution, by using a two-
dimensional charge-coupled device (CCD) detector
array, allows monitoring the biomolecular interac-
tions to determine kinetic and analytical parameters.
The output of this instrument is an image with dif-
ferent spots where the light intensity is proportional
to the different analyte concentration that interacts
with the biorecognition element. Thanks to this 2D-
detector it is possible to detect small SPR signal
variation [30].
By comparing SPRi with a conventional bulk SPR, the
advantages of SPRi are the possibility of detecting more
biomarkers at the same time, with an enhanced sensitivity
and selectivity. Colloidal nanoparticles (NPs) improve the
sensitivity of SPRi to ensure rapid, proper, and sensitive
analysis. The focus point of SPRi is the optical part of the
instrument where the light is addressed to different spots,
properly modified, to produce an SPR image thanks to the
reflected light [31].
Finally, in Table 2 the main advantages and drawbacks
of bulk, localized, and imaging SPR analytical techniques are
reported.
2. Nanomodified SPR-ABBs Applications for
In Vitro Diagnostics
Adetailed description of recent applications of nanomodified
SPR biosensors for IVD applications is reported.
2.1. Bulk SPR. To enhance the SPR sensitivity metal nanopar-
ticles are often used; this is accomplished throughout differ-
ent approaches: (i) nanoparticles directly incorporated into
the surface, (ii) entrapment of nanoparticles in structures
for spacing control, (iii) sandwich assay format by func-
tionalization of nanoparticles, (iv) employment of magnetic
nanoparticles, and (v) enzyme-conjugated nanoparticles.
In the first papers, MNPs were directly incorporated
into the electrode surface, as reported in the following
works where biosensors are described for several biomarkers.
Several examples deal with different arrangements employing
AuNPs to enhance sensitivity towards low molecular weight
molecules: Jung and coworkers developed an SPR biosensor
for the detection of prostate-specific antigen (PSA), a cancer
biomarker, by immobilizing AuNPs onto a SiO
2
layer on
a gold electrode and the results were compared with those
obtained with both an unmodified gold surface and a SiO
2
layer on a gold surface. The detection limit of the biosensor
was 0.1 ng/mL for PSA, which is comparable to the values
obtained with standard ELISA tests with sensitivities in the
range 0.1–10 ng/mL [32].
Li et al. realized an SPR biosensor for the determination
of ischemia modified albumin (IMA), a biomarker capable
of reflecting myocardial ischemia condition, by assembling
anti-IMA onto an AuNPs modified gold chip. Here IMA
was detected at 10 ng/mL and no interferences were reported.
The modified biosensor showed also high sensitivity thus
providing an effective new approach for a direct assay of IMA
[33].
Progesterone, an important reproductive hormone, was
detected by Yuan et al. by an ultrasensitive SPR inhibi-
tion immunoassay using a mixed self-assembled monolayer
(mSAM) surface to keep the AuNPs close to the sensing
surface. Progesterone was conjugated to ovalbumin with
an oligoethylene glycol linker to form a protein conjugate,
immobilized onto the mSAM surface, and then detected
with a low detection limit of 4.9 ng/mL. Furthermore, the
technique uses inexpensive reagents, and the stable mSAM
surface provides multiple reuses [34].
An innovative approach for the employment of AuNPs is
the possibility of AuNPs entrapment in structures for spacing
control. In fact, the spacing between particles and surface was
found to have a significant influence on the enhancement
of the SPR signal [35]. One possibility for achieving this
enhancement is the encapsulation of the particles into den-
drimers. An SPR biosensor for detection of insulin in human
serum using a bifunctional hydroxyl/thiol-functionalized
fourth-generation polyamidoamine dendrimer to encapsu-
late AuNPs has been reported by Frasconi et al. The resulting
AuNPs dendrimer-modified surface is a good support for
insulin immobilization. The immunosensor based on an
indirect competitive immunoassay principle showed high
sensitivity, specificity, and stability for detection of insulin in
human serum with a detection limit of 0.5 pM [36].
Another option is the entrapment of AuNPs intomolecu-
larly imprinted polymers (MIPs). An SPR sensor chip for the
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Table 2: Main advantages and drawbacks about bulk SPR, localized SPR, and SPR imaging transduction in ABBs.
Bulk SPR Localized SPR SPR imaging
Advantages
Label-free ∙∙ ∙∙∙ ∙∙∙
Real-time monitoring ∙∙∙ ∙∙∙ ∙∙∙
Sensitivity ∙ ∙∙ ∙∙∙
Multidetection array — ∙∙ ∙∙
Reusability ∙∙ ∙∙ ∙∙
Being easy to perform ∙∙ ∙∙ ∙∙
Low sample/ligand volume required ∙∙ ∙∙∙ ∙∙∙
Drawbacks
Steric hindrance ∙∙ ∙ ∙
Nonspecific adsorption of proteins ∙∙ ∙ ∙
Low molecular weight detection ∙∙ ∙ ∙
(∙) Low, (∙∙) moderate, and (∙∙∙) high.
detection of dopamine using a molecularly imprinted poly-
mer with embedded AuNPs, immobilized on a decanethiol-
modified Au chip, was described by Matsui et al. The sensing
principle is based on swelling of the imprinted polymer gel
triggered by the analyte binding within the polymer gel,
which increases the distance between AuNPs embedded in
the film resulting in a change of the SPR signal. Both the
analyte binding process and the consequent swelling are
reversible processes thus allowing the repeated use of the
presented sensor chip [37].
Better results were obtained when MNPs are conjugated
with antibodies or aptamers in the “sandwich assay” format,
as reported in the following papers.
Choi et al. realized an ultrasensitive SPR affinity device
based on the conjugation of AuNPs and the polyclonal anti-
body for PSA detection. The monoclonal antibody is highly
oriented onto the surface thanks to the first layer formed
by rProtein G deposited on the surface by self-assembled
monolayer.The highly oriented antibody immobilized on the
surface and the conjugation with AuNPs-antibody allowed
the detection of PSA in the femtomolar range (detection limit
300 fM), with a good linearity range, thus increasing 1000-
fold the sensitivity of PSA detection compared to previous
works [39].
Another example of a sandwich configuration is the
AuNPs modified SPR biosensor for the detection of human
cardiac myoglobin (cMb) in serum based on a reverse sand-
wich assay, described by Gnedenko and coworkers. A first
monoclonal anti-cMB antibody was covalently immobilized
on the sensor surface and then AuNPs were covalently
immobilized to the second monoclonal anti-cMb antibody.
The limit of detection of cMb in a human blood serum sample
was found to be as low as 10 pMwith an intra-assay coefficient
variation of less than 3% [40].
Sˇpringer andHomola developed an SPR affinity biosensor
to detect low levels of carcinoembryonic antigen (CEA) in
human blood plasma based on a new biofunctionalization of
AuNPs. The AuNPs were functionalized either with strepta-
vidin, to provide high affinity for the biotinylated secondary
antibody, or with bovine serum albumin, to minimize the
nonspecific adsorption of proteins during the analysis of
complex samples like blood plasma. The basic concept of
this approach is the sandwich assay format using a primary
antibody immobilized on the surface, the antigen CEA with
different concentrations, and the biotinylated secondary anti-
body bound with the bio-AuNPs. This approach makes the
detection of CEA at concentrations of 0.1 ngmL−1 possible,
much lower than normal physiological levels [41].
In a successive work, Sˇpringer and coworkers also studied
the effects of AuNPs on the response of an SPR sensor for
the detection of a carcinoembriogenic antigen (CEA). AuNPs
were functionalized with neutravidin (N-AuNPs) in a sand-
wich assay format in order to enhance the sensor response to
a biotinylated secondary antibody against CEA. The authors
demonstrated that the sensor response enhancement was
determined by two factors, both depending on the size of
AuNPs: sensor sensitivity toN-AuNPs surface density and the
ability ofN-AuNPs to bind functionalized sensor surface [35].
In other cases, the “sandwich assay format” can be
realized by functionalizing theMNPswith aptamers, artificial
single-stranded DNA, or RNA sequences with extremely
high affinity and specificity for specific targets. Compared
to traditional antibodies, aptamers have unique properties
such as low immunogenicity, ease of chemical modification,
and high structural stability and flexibility. Therefore MNPs-
based SPR aptasensors combinedwith sandwich assays repre-
sent an alternative strategy to detect proteins with enhanced
sensitivity and selectivity.
A sandwich format with aptamer/thrombin/aptamer-
AuNPs system on an SPR sensor for subnanomolar detection
of thrombinwas described byBai et al.The sensormechanism
is based on the simultaneous binding of thrombin to differ-
ent aptamers at two exosites. One thiol-modified thrombin
aptamer was immobilized on AuNPs via Au-S bonding. The
other biotinylated thrombin aptamer was grafted onto strep-
tavidin pretreated SPR gold film through biotin-streptavidin
recognition. Thrombin is able to create a double aptamer
sandwich structure on the SPR gold surface which allows a
large enhancement of the SPR signal.Thrombin was detected
in the range 0.1–75 nMwith a detection limit of 0.1 nM, 5-fold
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lower than that obtained in a direct detection format without
AuNPs [43].
Jang and coworkers developed a novel approach for
the ultrasensitive detection of the brain natriuretic peptide
(BNP), a short peptide recognized as a cardiac biomarker,
based on a “sandwich assay” DNA aptamer-biomarker-
antibody. This method was realized by chemical binding of
DNA aptamer on the surface by self-assembling, followed
by the affinity recognition with the biomarker, BNP, and
the antibody. The antibody was labeled with gold nanocubes
(AuNCs) in order to enhance the SPR signal by increasing
the mass immobilized onto the surface. The combination of
AuNCs labeling and the particular sandwich assay format
allows reaching detection limits in the attomolar range,
avoiding the nonspecific adsorption of proteins [44].
Also gold nanorods can be used in the “sandwich assay”
format to detect concentrations in the femtomolar range.
Law et al. proposed a gold sensor chip modified with 3-
mercaptopropionic acid (MPA) self-assembled monolayer
that allows the immobilization of monoclonal antibody for
the detection of tumor necrosis factor alpha (TNF-𝛼) antigen.
The immunoreaction between the antigen, TNF-𝛼, and the
secondary antibody bioconjugated with gold nanorods is
an ultrasensitive method to increase the sensitivity. The
detection limit of TNF-𝛼 antigen was 0.5 ngmL−1, much
lower than the physiological value of this antigen [42]. Other
strategies to reach detection limits in the subattomolar range
involved the use of dual nanoparticles. Baek et al. used
two different AuNPs shapes, nanorods (NRs) and quasi-
spherical nanoparticles (qsNPs) to realize an SPR affinity
biosensor for thrombin (Thr) detection. The modification
was carried out with a covalent binding of antithrombin
using a mixed self-assembled monolayer. After the affinity
recognition of the antigen, the interaction with a DNA pair
modified with a polyadenine tail took place. The following
step was the matching with the complementary polythymine
aptamer (pT) previously modified with qsNPs, followed by a
dual interaction with another polyadenine aptamer, modified
with NRs for a double SPR signal enhancement. The sensor
chip allowed detecting thrombin concentrations as low as
0.1 aM,with a 10-fold sensitivity enhancement comparedwith
a simple NPs modification [45].
Rolling circle amplification (RCA) is an advanced molec-
ular amplification technique, recently used to amplify the
SPR signal. He et al. detected human thrombin using SPR
and quartz crystal microbalance (QCM) sensing platforms
in combination with aptamer-based rolling circle amplifica-
tion and bio-bar-coded AuNPs enhancement. Thrombin was
detected in the range 1 aM–0.1 pMwith an excellent detection
limit of 0.78 aM. In the absence of amplification the detection
limit for thrombin was about 0.1 nM, thus showing 4 orders
of magnitude improvement in the presence of RCA [46].
Also magnetic nanoparticles (MNPs) can be used as
labels. They have been receiving increasing attention because
of their high refractive index and high molecular weight
which allow them to be successfully used as amplifying
agents in SPR biosensing design. Wang et al. demonstrated
that the addition of antithrombin aptamer-Fe
3
O
4
MNPs
conjugates greatly enhances the sensitivity of an SPR sensor
for the detection of thrombin. Thrombin was captured by
immobilizing antithrombin aptamer on SPR gold film with
a very low detection limit of 0.017 nM, thus confirming that
MNPs are a powerful sandwich element and an excellent
amplification reagent for SPR-based sandwich assays. The
limit of detection obtained was lower than that obtained for
the sandwich assay with AuNPS, but higher than with the use
of rolling circle amplification [47].
Liang et al. used the core-shell Fe
3
O
4
-Au magnetic
nanoparticles (MNPs) as amplification method for the detec-
tion of human 𝛼-fetoprotein (𝛼-FET). The gold sensor
chip was modified with a film formed by 3-mercapto-
1-propanesulfonate/chitosan-ferrocene/AuNPs, followed by
the covalent binding of primary antibody and bovine serum
albumin (BSA) to avoid the nonspecific adsorption of pro-
teins. Successively, there was the affinity recognition with the
target and secondary antibody bioconjugated with the core-
shell Fe
3
O
4
-AuNPs. The calibration curve of 𝛼-fetoprotein
was obtained in the range 1–200 ngmL−1, with a LOD of
0.65 ngmL−1 [48].
Recently, superparamagnetic nanobeads were used for
SPR signal amplification. Soelberg and his coworkers devel-
oped a method for rapid purification, concentration, and
detection of Staphylococcal Enterotoxin B (SEB) using
antibody-coated superparamagnetic nanobeads. The sen-
sitivity was 10-fold enhanced with a detection limit of
100 pgmL−1. The “sandwich assay” approach was provided
with the monoclonal antibody immobilized onto the sur-
face and the secondary antibody bioconjugated through the
biotin-streptavidin interaction between the antibody and the
magnetic beads [49].
Another approach for SPR signal amplification concerns
enzymatic precipitation, as described by Cao and Sim: the
authors described a method based on the synthesis of an
AuNPs-enzyme conjugate for the amplification of the SPR-
based detection of anti-glutamic acid decarboxylase antibody
(anti-GAD), an autoantibody present in the serum of insulin-
dependent diabetes mellitus patients. The AuNPs were cova-
lently conjugated with horseradish peroxidase (HRP) and
anti-IgG antibody to form an enzyme-immunogold complex.
The combination of AuNPs and enzyme precipitation is the
strategy used for signal enhancement. Anti-GAD Ab was
detected at a concentration as low as 0.03 ngmL−1 [69].
The main characteristics of the biosensors reviewed in
this section are summarized in Table 3.
2.2. Localized SPR. One of the main important challenges
in the LSPR performances enhancement is the improvement
of sensitivity and selectivity in complex media analysis. As
for bulk SPR, the LSPR-based ABBs sensitivity is improved
by using the sandwich assay configuration, through the
bioconjugation with antibodies or aptamers as biotransducer.
Mayer and coworkers reported the development of
gold nanorods based LSPR biosensor. The nanorod surface
was functionalized with a self-assembled monolayer and
bound to the antibody using carbodiimide cross-linking.
The interactions with a secondary antibody were studied
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by monitoring the shift in the LSPR signal resulting in a
little binding of the nonspecific secondary antibody. These
findings demonstrated that the nanorod-based LSPR sensor
could be able to perform the real-timemonitoring of dynamic
interactions in the same way of bulk SPR, but with much
simpler instrumentation required [28].
Haes et al. realized an LSPR biosensor for the deter-
mination of biomarker of Alzheimer’s disease by mea-
suring the interactions between amyloid-derived diffusible
ligands (ADDL) and the anti-ADDL antibody, involved in
Alzheimer’s disease. Alzheimer’s disease (AD) is a progressive
mental disorder disease widely diffused in the world; since a
specific cure is unavailable at present, an early diagnosis of
AD is a crucial point for the existing drug treatments. Based
on a sandwich assay format the proposed biosensor showed
quantitative binding information for both antigen and sec-
ondary antibody detection allowing the determination of
ADDL concentration which is higher in disease patients in
comparison to the control patients [50].
Park et al. realized an LSPR biosensor using multispot
gold-capped silica nanoparticle array chip for detection of
avian influenza (A) virus, an infectious viral disease. A metal
binding polypeptide (GBP)-fusion protein was bound onto
the gold substrates by means of specific interactions allowing
immobilization of proteins in bioactive forms onto the gold
surface suitable for immunosensors applications. Following
this procedure, an ultrasensitive detection of avian influenza
virus was successfully achieved up to 1 pgmL−1 [51].
A highly sensitive LSPR immunosensor was proposed
for the detection of HIV-1 virus based on the realization
of a nanopattern of circular gold nanodots which was elec-
trodeposited onto an indium tin oxide coated glass substrate
[52]. The resulting modified surface was then functionalized
with the HIV-1 antibody fragments allowing the measure-
ments of various concentrations of HIV-1 particles with
a detection limit of 200 fgmL−1, 10-fold higher than that
of previously reported virus detection method based on
LSPR. This approach could be useful for the development of
biodevices for the analysis of several viruses’ detection.
Chen et al. realized a simple and affordable LSPR-based
device for the highly sensitive detection of both extracellular
adherence protein (EAP), found on the outer surface of the
bacterium Staphylococcus aureus (S. aureus), and prostate-
specific antigen (PSA).The EAP, a protein of 60 kDa excreted
by S. aureus, has affinity for both eukaryotic cells and
the surface of S. aureus itself. The sensor chip surface
was modified by self-assembling to immobilize the specific
antibodies for EAP and PSA detection, which are anti-EAP
and the monoclonal anti-Kallikrein 3 (anti-Klk3) for anti-
PSA. This device showed a high sensitivity, with a LOD of
8 nM for EAP and 1 pM for PSA. These experiments can
be considered as a proof of concept for the development
of high-performance biosensing platform for point-of-care
diagnostics applications [53].
Zhao and coworkers developed an LSPR biosensor for
the detection of serum squamous cell carcinoma antigen
(SCCa), a well-known tumor biomarker important for the
early diagnosis of cervical cancer diseases, which is one of the
most widespread cancers in women. The LSPR biodevice is
based on the use of a triangle-shaped silver nanoparticle array
obtained by nanosphere lithography method, with mono-
clonal anti-SCCa antibodies immobilized onto the resulting
surface. Several concentrations of SCCa were measured both
in buffer and in human serum with a linear detection range
of 0.1–1.000 pMwith a LOD of 0.125 pM.This device could be
useful as a potential alternative to the traditional technique
commonly used in the diagnosis of cervical cancer diseases
[54].
Ac´imovic´ et al. developed an application of a paral-
lel LSPR biodevice with enhanced analytical performances
(high-throughput, fast, and real-time monitoring) for the
analysis of two well-known cancer markers: human alpha-
feto-protein (AFP) and PSA. The system device enables
the simultaneous, real-time analysis of 32 sensing spots
distributed across eight independent microfluidic channels.
Each spot is obtained by the deposition of gold nanorods
onto a glass substrate in line. The isolation among each array
is achieved by a polydimethoxysilane (PDMS) microfluidic
interface controlled by micromechanical valves. The detec-
tion of the cancer markers can be performed in a dual
configuration: (a) direct format; (b) sandwich format by using
a secondary antibody. This system allowed the detection of
the two cancermarkers down to concentrations of 500 pg/mL
in a real serum matrix [55].
Yuan et al. carried out a study to develop a novel LSPR
biosensor for detecting human epididymis secretory protein
4 (HE4) biomarker in blood samples for the early diagnosis
of ovarian cancer. On the surface of silver nanoparticles,
obtained by nanosphere lithography method, was immobi-
lized the anti-HE4 antibody by using an amine coupling
method.Theperformances of the device allow a fast, accurate,
and reproducible analysis with a linear range ranging from
10 pM to 10,000 pM and a LOD of 4 pM [56].
Lai et al. realized an almost similar approach based on
the same Ag nanoparticles modification of the sensor surface
for the detection of microalbuminuria in urine samples.
Screening microalbuminuria could identify the patients that
are at high risk for cardiovascular events with pregnancy-
induced hypertension and diabetes mellitus. An amine cou-
pling procedure was employed to immobilize the anti-human
albumin antibody on the sensor surface. The biosensor
displayed short analysis time (about 40 minutes), a detection
limit of 1 ng/mL, and a wide dynamic range of 1 ng/mL to
1 𝜇g/mL [57].
Duan and coworkers developed a nanobiosensor based
on LSPR for detecting p53 mutation. p53 is a key tumor
suppressor that plays crucial roles in the induction of cell
cycle arrest and apoptosis as a consequence of DNA damage.
p53 mutations, especially those occurring in L2 and L3 zinc
binding domains, are strongly associated with radiotherapy
and chemotherapy-resistance. The detection of p53 mutation
is of extreme importance to speed up the diagnosis of tumor
patients. The DNA probe was designed to recognize the
target sequence and immobilized on the chip surface by a
covalent coupling method using amine-group ligands. Syn-
thetic oligonucleotides or PCA products were amplified from
genomic DNA taken from blood samples and hybridized
with the immobilized probe. The detection limit of the
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Table 4: Main analytical performances of the reviewed biosensors based on localized SPR.
Analytes Nanoparticles Biotransducer Detection limit (LOD) IVDD class References
Amyloid-derived diffusible ligands (ADDL) AuNPs Antibody — C Haes et al., 2005 [50]
Avian influenza (A) AuNPs Antibody 1 pgmL−1 C Park et al., 2012 [51]
HIV-1 AuNPs Antibody 0.2 pgmL−1 D Lee et al., 2013 [52]
Extracellular adherence protein (EAP)/PSA AuNPs Antibody 8 nM/1 pM C Chen et al., 2009 [53]
Squamous cell carcinoma antigen (SCCa) AuNPs Antibody 0.125 pM C Zhao et al., 2014 [54]
𝛼-fetoprotein (AFP)/PSA AuNPs Antibody 41 zM C Ac´imovic´ et al., 2014 [55]
Human epididymis secretory protein 4 (HE4) AgNPs Antibody 4 pM C Yuan et al., 2012 [56]
Microalbuminuria AuNPs Antibody 1000 pgmL−1 C Lai et al., 2010 [57]
p53 mutation AgNPs Antibody 10 nM C Duan et al., 2012 [58]
NADH AuNPs Antibody — B Gu et al., 2015 [59]
sensor was 10 nM with a dynamic range from 10 nM up to
10 𝜇M. The sensor was able to discriminate differences in
measuring signals between wild-type and mismatched p53
DNA, demonstrated to be able to discriminate effectively
against single base mutations. The results obtained with
this biosensor suggested that it can represent an attractive
alternative for clinical detection of genetic mutations [58].
Gu et al. proposed an automatic, robust, and high-
throughput method to study the resonance scattering light
of single plasmonic nanoparticles in the dark-field image for
intracellular analysis, thus demonstrating that this approach
allows obtaining detailed and reliable information for moni-
toring the distribution of NADH in cancer cells and estimat-
ing the efficiency of cancer drugs [59].
The main characteristics of the biosensors reviewed in
this section are summarized in Table 4.
2.3. SPR Imaging. An important strategy to improve the
reverse chemical genetics was the small-molecule microarray
technology development to observe every possible small-
molecule-protein interaction. In the last years several pro-
cedures were developed to avoid the nonspecific adsorption
of proteins and the structural adsorption of small molecule
not due to chemical binding [70–73]. To observe interactions
between small molecules and proteins, these latter were
labeled with a fluorescent molecule, but sometimes there are
incompatibilities reducing the protein functionalities [74].
An alternative procedure to detect the interaction and to
determine kinetic, thermodynamic, and affinity parameters
without labeling is the surface plasmon resonance imaging
(SPRi) [75–77].
SPRi has been used to characterize thin organic and
biopolymer films at metal interfaces in a spatially resolved
mode. This approach enables the measurement of interac-
tions between unlabeled biological molecules and surface-
bound species in an array format. Hence, SPR imaging is
thought to be well-suited not only for DNA and protein
microarrays but also for small-molecule microarrays [78–81].
Indeed, a variety of small molecules have been introduced
on SPR biosensors for analyzing interactions between these
molecules and proteins; however, the immobilization proto-
col had to be optimized for the respective small molecules
[82–84].
In this section, many approaches based on the nanopar-
ticles were presented with particular attention to the surface
modification and the nanoparticle functionality. In fact, they
work not only as a labeler but also as a simple amplifier
because of the interaction with evanescent wave onto the sur-
face [85–87]. We make a comparison between the following
examples focusing on the sensitivity, the modification, and
the class of biomarker. Mainly, the biosensors based on SPR
imaging can be divided into two groups even if the major
part is formed by DNA/RNA aptamer affinity platform, as
reported in Table 5.
Sendroiu et al. developed a DNA multidetection array
based on the SPR imaging for the detection and identification
of nucleic acids. The gold surface was modified by using
amine-modified ssDNA elements in order to create four
generator elements, where the ssDNA have a complementary
sequence for the transcription of RNA with a partially com-
plementary sequence; around them there are eight detector
spots, where the ssDNA, modified with 13 nm gold nanopar-
ticles in order to enhance the SPR response, were partially
complementary with the ssRNA transcripts. On the surface
there are two positive and two negative controls to verify
the possible nonspecific adsorption of proteins. In summary,
this modification allows detecting the RNA transcripts in the
concentration range from 1 fM to 10 pM [60].
A new multidetection method to detect short RNA by
using enzymatic and modified silica nanoparticles (SiNPs)
amplification to enhance SPR imaging signal was realized
from Zhou and his coworkers. SiNPs were functionalized
with 5󸀠-phosphorylated single-stranded DNA (ssDNA) cou-
pled with T4 RNA ligase to capture different single-stranded
RNA (ssRNA) from a target solution.This procedure by using
modified SiNPs presents several advantages: (i) larger surface
area exposition to target solution containing ssRNA; (ii)
increase of ssRNA diffusion rate thanks to modified SiNPs;
(iii) SPR imaging signal enhancement by using SiNPs. The
preliminary measurements demonstrate that this detection
method can be used to investigate multiple ssRNA sequences
at concentrations as low as 100 fM in 500𝜇L [61].
Fang et al. developed a new approach for the miRNAs
detection by using a locked nucleic acids (LNA) modified
surface tomonitor concentration down to 10 pMwith the SPR
imaging [62]. In the first step, there is the complementary
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Table 5: Main analytical performances of the reviewed biosensors based on SPR imaging.
Analytes Nanoparticles Biotransducer Detection limit (LOD) IVDD class References
Nucleic Acid AuNPs Aptamer 1 fM C Sendroiu et al., 2011 [60]
miRNA SiNPs Aptamer 100 fM C Zhou et al., 2011 [61]
miRNA AuNPs Aptamer 5 aM C Fang et al., 2006 [62]
DNA AuNPs Aptamer 10 aM C Gifford et al., 2010 [63]
Single nucleotide polymorphisms (SNPs) AuNPs Aptamer 1 pM C Li et al., 2006 [14, 15]
Single nucleotide polymorphisms (SNPs) AuNPs Aptamer 32 nM C Sato et al., 2006 [64]
DNA AuNPs Aptamer 41 zM C D’Agata et al., 2010 [65]
DNA AuNPs Aptamer 0.02 aM C Yao et al., 2006 [66]
miRNA AuNPs Aptamer — C Wood et al., 2013 [67]
IgG AgNPs Antibody 1 nM B Paul et al., 2011 [68]
interaction between the LNA and the miRNA with 3󸀠-OH
end group disposable to bind a polyadenine tail by pA-
polymerase. Successively, the recognition interaction with
polythymine tails modified with gold nanoparticles in order
to amplify the SPR imaging signal to allow the detection of
low miRNA concentrations was carried out. The multiplexed
detection of miRNAs with DNAmicroarrays is a particularly
appealingmethod for miRNA profiling in biological samples.
Using this technique, Corn’s research group has been
able to detect simultaneously three different miRNAs present
in total RNA sample extracted from mouse liver. A four-
component microarray was constructed containing three
LNA probes designed to bind to miR-16, miR-122b, and miR-
23b miRNA sequences, with a DNA probe used as a negative
control. The concentration of the different miRNA species in
the solution has been calculated from calibration curves of
the SPRi response signal obtained using synthetic analogs of
the target sequences, and the amount of miRNAs in the total
RNA sample was estimated to be 20 fM, 50 fM, and 2 pM for
miR-16, miR-23b, and miR-122b, respectively. The detection
limit of this amplified SPRi methodology was found to be 5
attomoles, which is at least 50 times more sensitive than the
fluorescent-based microarray detection methods.
The variety of SPR imaging biosensing applications can
be expanded by enzymatic manipulation of DNAmicroarray
elements, and the sensitivity of detection can be enhanced by
the use of oligonucleotide immobilized onto a gold nanopar-
ticle surface. Gifford et al. developed a new method where
a template-directed polymerase extension of a surface array
element and nanoparticle-enhanced detection of the reac-
tion product were coupled. This technique allows detecting
concentrations of the polymerase in the linear concentration
range of 10–100 attomoles through the DNA target produced.
This sensitivity would allow for the detection of a specific
DNA target that is present in low amounts in a sample and
with partially unknown sequence. One application of this
method would be to identify the presence of the aberrantly
recombined DNA sequences, such as those found in the
fragile sites of chromosomes [63].
A sensitive method based on nanoparticle-enhanced sur-
face plasmon resonance imaging to detect single nucleotide
polymorphisms (SNPs) in genomic DNA was realized from
Li and his coworkers. Sequence-specific surface reactions
of the enzyme Taq DNA ligase were used to investigate
SNPs, and the presence of ligation products on the DNA
microarray elements was detected using SPRi through the
hybridization adsorption of complementary oligonucleotides
labeled to gold nanoparticles. The concentration of 1 pM
was successfully identified thanks to the gold nanoparticles
amplification that allowed improving the SPRi sensitivity
[14, 15].
This sensitivity is sufficient enough for performingmulti-
plexed SNP genotyping by usingmultiple PCR amplicons and
should also allow for the direct detection and identification of
SNP sequences from 1 pM unamplified genomic DNA sam-
ples with this array-based and label-free SPRi methodology.
As a first example of SNP genotyping, three different human
genomic DNA samples were screened for a possible point
mutation in the BRCA1 gene that is associated with breast
cancer.
Recently Sato et al. reported that gold nanoparticles
(GNPs) with fully matched duplexes on their surfaces are
selectively deposited onto walls of poly(dimethylsiloxane)
(PDMS) microchannels at high salt concentrations. In
this study, the surface plasmon resonance (SPR) imaging
technique was used to investigate this phenomenon for
improvement of detection sensitivity and elucidation of
the phenomenon. The microchip was realized by bonding
a surface-patterned PDMS plate and a gold thin film-
deposited glass substrate. Probe oligonucleotide-modified
GNPs were hybridized with target oligonucleotides to make
fully matched or single-base-mismatched duplexes. The
hybridized GNP solution was mixed with a NaCl solution in
a Y-shaped microchannel [64].
SPR imaging allowed controlling the GNP deposition
but also discriminating the targets with limit of detection
of 32 nM (19 fmol) without temperature control in 5min.
Therefore, in combination with a portable SPR device, the
proposed method is promising for point-of-care testing of
single nucleotide polymorphisms [88, 89].
For a proper DNA detection the technologies available
today are based on the combination of labeled probes and
target sequences amplified by polymerase chain reaction
PCR. The elimination of PCR and labeling is the focus
point in order to develop a new biosensor for early, proper,
and low-cost analysis [65]. In this work D’Agata et al.
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describe the results obtained in the ultrasensitive detection
of nonamplified genomic DNA. Certified reference mate-
rials containing different amounts of genetically modified
DNA by using a detection method which combines the
nanoparticle-enhanced surface plasmon resonance imag-
ing (SPRi) biosensing to the peptide nucleic acids (PNAs)
improving selectivity and sensitivity in targeting comple-
mentary DNA sequences were realized. The method allowed
obtaining a 41 zM sensitivity in targeting genomic DNA even
in the presence of a large excess of noncomplementary DNA.
Yao et al. reported the development of oligonucleotide
(ODN) coating gold nanoparticles (Au–NPs) amplification
in a sandwich assay of ODN or polynucleotide by a flow
injection surface plasmon resonance (SPR) imaging.The disk
surface was modified by spreading a carboxylated dextran
film to minimize the aspecific adsorption of ODN coating
Au–NPs. The synergic action of oligonucleotide enhanced
loading and AuNPs plasmonic effect results in a signal
amplificationmeasured by the bicell detector on the SPRwith
a notableDNALODof 2.1× 10−20mol.This biosensor showed
high reproducibility and specificity and could be employed
also for the p53 cDNA (a cellular tumor antigen) analysis [66].
Wood and her coworkers [67] reported a single step
polymerization of polydopamine (PDA) films onto a thin
film gold substrate and then employed it in the develop-
ment of DNA microarrays for the sensitive detection of
biomolecules with nanoenhanced surface plasmon resonance
(SPR) imaging. The PDA multilayer thicknesses, ranging
from 1 to 5 nm, were characterized by means of scanning
angle SPR and AFM techniques, and a 1.3 ± 0.2 nm PDA
multilayer thickness was chosen as optimal for the SPR
imagingmeasurements.TheDNAmicroarrays were obtained
by coupling the amine-functionalized single-stranded DNA
(ssDNA) oligonucleotides with PDA-modified gold thin film
microarray element. Then they were employed in the mea-
surements of DNA hybridization adsorption and protein-
DNA binding [90–92]. The PDA multilayer showed good
resistance to the nonspecific binding of biomolecules. The
results obtained suggest the possible use of these ssDNA
microarrays for the detection of miRNA.
An affinity immunoreaction sandwich by using CCD
detector to capture the SPR image at visible wavelength
was realized from Paul and his coworkers. The sur-
face modification started with a self-assembling of 11-
mercaptoundecanoic acid in order to immobilize the primary
anti-immunoglobulin G. Successively, BSA injection was
performed to avoid the nonspecific adsorption of proteins
onto the surface.The next step was the immunoreaction with
the antigen, immunoglobulin G (IgG), and the secondary
antibody labeled with silver nanoparticles to increase the SPR
signal.
The device allows investigating the IgG concentration in
the linear range of 6.66–660 nM, ensuring a lower detection
limit of 2 nM with the electroaddressing of the secondary
antibody, and a lower detection limit of 1 nM in the presence
of other low molecular weight proteins [68].
The main characteristics of the biosensors reviewed in
this section are summarized in Table 5.
3. Conclusions
The most recent advances about the employment of nanos-
tructures in SPR allowed greatly enhancing the analytical
performances of in vitro diagnostics. In particular, bulk SPR
devices took great advantages from the use of these materials
getting to lower the limit of detection to fractions of ng/mL
and sometimes to concentrations levels lower than 0.5 pM.
This was made possible thanks to different approaches such
as the encapsulation of the particles in dendrimers and the
development of sandwich assay formats that in some cases
enable detecting concentration as low as in the femtomolar
range. On the other hand, the detection limits in subattomo-
lar range can be reached by different strategies based on the
use of dual nanoparticles.
The localized SPR-basedmethods can be used to monitor
real-time dynamic interactions in a similar manner to bulk
SPR, but withmuch simpler instrumentation; simple and cost
effective LSPR-based devices proved to be useful for detection
of extracellular proteins at attomolar levels.
Lastly, the SPR imaging-based methods have been shown
to represent an alternative procedure to analyze interac-
tions of either DNA, protein microarrays, or small-molecule
microarrays and to determine kinetic, thermodynamic, and
affinity parameters thereof without labeling. Amplified SPRi
methodologies accomplished detection limits as low as atto-
molar levels, which is at least 50 timesmore sensitive than the
fluorescent-based microarray detection methods.
The outlook of SPR techniques employed as IVDDs
will go in two directions: (i) miniaturization in order to
obtain portable and reliable devices for in situ analysis; (ii)
enhancement of the performances by using nanotechnology-
based modifications.
Among future trends of IVDDs, the employment of
point-of-care (POC) devices will receive growing interest
due to their characteristics of high accuracy and nonin-
vasive devices also suitable for continuous monitoring. In
particular, the POC tests will become an excellent choice for
the diagnosis of infectious diseases in developing countries,
mostly where those diseases are endemic, thanks to the
possibility of being easily transported, installed, and also used
by nonspecifically trained personnel. Also, to overcome issues
of cost and improving performances of simple devices, it can
be expected that configurations based on cheap substrates
and readily available reader devices such as tablets or cellular
phones will grow dramatically in the near future.
In fact, instead of focusing on enhancing the performance
of the transduction system, the actual trend is more devoted
towards addressing either nonspecific response or limitations
of recognition-based reaction affinity. In this respect, a
significant trend is the employment of aptamers instead of
antibodies for the specific binding of proteins. Even if this
technology has scored only a small number of successes so far,
it will gain more attention as it entails the use of synthetically
generated reagents in place of highly complex biomolecules
obtained by living organisms and therefore often variable.
In our opinion, the synergic effect in the field of optics,
nanotechnologies, microfluidics, biotechnologies, and sur-
face chemistry will result in the development of improved
12 International Journal of Analytical Chemistry
SPR affinity biodevices which will be able to be used as an
alternative to the traditional methods commonly employed
for the in vitro diagnostics.
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